NASA announced the four astronauts who will fly to space as soon as next year to test out moon landers built by SpaceX and Blue Origin — the next stage in the agency’s ambitious Artemis program to ultimately send humans back to the lunar surface. The newly assigned crew includes NASA astronauts Andre Douglas and Frank Rubio, who will serve as mission specialists. They’ll be joined by Italian astronaut Luca Parmitano, the mission’s pilot, and NASA’s Randy Bresnik, the flight’s commander. The upcoming Artemis III mission is slated to fly as early as 2027. The crew will not be heading to the moon’s vicinity. Instead, they’ll fly into orbit around the Earth on a roughly two-week trip to test the landers, which eventually will be used to take humans to the lunar surface as soon as 2028. Working landers are critical to the long-term success of the Artemis program, which aims to eventually establish a base on the moon where humans can live and work. NASA has also said the lessons learned will help prepare the agency for future missions to Mars. “To the Artemis III crew, we wish you Godspeed on the journey ahead,” NASA Administrator Jared Isaacman said Tuesday during a ceremony introducing the crew. “You carry the fire of exploration from generations past, the confidence of this agency and the support of this nation.” Artemis III is slated to occur about a year after the Artemis II launch, which sent four astronauts around the moon in April. That mission tested the prowess and safety of the Boeing Co. -built Space Launch System rocket and the Lockheed Martin Corp. -manufactured Orion crew capsule. Artemis III was originally intended to be the first mission to land US astronauts on the moon since Apollo 17 in 1972. But in February, Isaacman changed it to a test mission to make the upcoming moon landing safer. The agency now aims to send humans back to the lunar surface in Artemis IV. NASA’s tentative plan for Artemis III is to first send Blue Origin’s lunar lander into orbit...

Jajah-sireenut/E+ via Getty Images I’ve been cautious on Phathom Pharmaceuticals, Inc. ( PHAT ) in the past. This company markets Voquezna in the U.S. for erosive esophagitis, non-erosive GERD, and H. pylori infection. Outside of severe erosive esophagitis, I’ve noted that Voquezna faces an uphill battle in regards to market share due to dirt-cheap and broadly used proton pump inhibitors (PPIs) like Protonix. My analysis in January followed Phathom’s preliminary Q4 report. The company was growing Voquezna ~15% sequentially (Q/Q) while cutting down on expenses. I performed a DCF model on PHAT and ascertained that it was priced for 18.7% CAGR and 20% FCF margins, which seemed optimistic despite management’s operating profitability goal in 2H 2026. I ended a hold pending “clearer evidence of durable GTN, a steadier path to free cash flow, reducing financing overhang, and better long-term prospects (that support terminal value assumptions).” Phathom has since announced Q1 earnings, so I wanted to take another look. Recent Developments Image 1: PHAT Q1 2026 income statement visualization (Author's Compilation) Management narrowed its profitability goal to Q3 2026, but this is excluding stock-based compensation. So, as I alluded to in January, and this is particularly relevant for my DCF model, “operating profitability” does not automatically translate into actual cash generation. Management did point out that cash generation is expected next year. How are they going to achieve this? Expense discipline. The business is showing signs of operating leverage. Q1 revenues climbed 104% Y/Y, outpacing SG&A (down 43% Y/Y) and R&D (down 15% Y/Y). Stock-based compensation in recent quarters has dipped under 10% of revenue. And cash from operations is clearly trending in the right direction now that the commercial infrastructure is largely in place. Image 2: PHAT's operating cash flow (Seeking Alpha) Taking a closer look at Q1, sequential growth was just 1%. Management cited a “wint...

格隆汇6月10日｜恐慌指数VIX达到自4月7日以来的最高点；最新上涨2.72点，报21.64。

The biggest World Cup ever starts this week. Laura Williamson, editor in chief of The Athletic, describes how sky-high prices, travel restrictions, politics and the Ebola outbreak are impacting fans.

核心要点 苹果 在全球开发者大会上公布全新人工智能软件后，公司股价走低。 分析师整体对苹果本次发布内容持正面评价，称赞 Siri 迎来大幅升级。 但部分分析师认为本次发布会缺少重磅惊喜，难以在短期提振股价；尤其苹果并未给出新版 Siri 人工智能功能的正式上线日期，仅向开发者开放测试版。 苹果于昨日全球开发者大会上发布多款全新人工智能产品，受消息兑现 “卖事实” 情绪影响，该股周二下跌 3%，有望创下今年 2 月以来单日最大跌幅。 苹果推出名为 “苹果智能（Apple Intelligence）” 的全新开发框架，可供应用开发者在 iPhone 与 Mac 设备上调用苹果自研 AI 能力；同时发布基于大语言模型重构的全新 Siri——Siri AI。苹果还透露，公司正联合 谷歌 、英伟达，搭建性能对标前沿大模型的云端 AI 模型。 但资本市场上演 “利好落地即抛售” 行情，苹果股价创下 2 月以来最差单日表现。 分析师普遍认可本次发布会内容，高度肯定 Siri 的升级优化。但不少机构观点指出，整场发布会缺乏超预期重磅创新，无法短期拉动股价；尽管开发者现已可在测试版系统体验 Siri AI，苹果仍未敲定正式上线时间。 贝尔德证券分析师威廉・鲍尔在研报中写道：“苹果虽然描绘了完整的 AI 发展蓝图，展示了早期个性化、场景化 AI 应用场景，但仅计划于今年晚些时候推出 Siri AI 测试版，完整版上线时间尚无明确时间表，这也是今日盘中股价下跌的核心诱因。” 高盛 分析师表示，苹果将 AI 深度嵌入硬件生态有望带动新一轮设备换机周期，同时苹果可通过调用次数限制、订阅服务实现 AI 商业化变现。 高盛分析师吴迈克尔写道：“图像生成等功能依托高性能云端大模型运行，因此设置每日使用上限；用户升级 iCloud + 订阅套餐即可解锁更高使用额度，这将为苹果智能业务带来直接收入。” 摩根大通 分析师萨米克・查特吉指出，受各地监管政策约束，苹果 AI 功能在中国、欧洲市场上线将延后，且初期仅支持英文语种。 他在研报中称：“美国市场今年秋季上线 Siri AI，将有效拉动年末假日季电子产品销量；但后续产品向全球其他地区、多语种市场落地的进度，是投资者后续需要重点跟踪的关键指标。” 瑞银 分析师戴维・沃格特认为，当前消费者可选 AI 产品繁多，苹果智能很难给用户带来颠覆性体验；他判断这批...

保加利亚国防部长斯托亚诺夫在索菲亚表示，保加利亚将停止对乌克兰的军事援助。他认为，俄乌冲突无法在战场上解决，现在俄乌双方需要通过谈判寻求和平。自2022年俄乌冲突爆发以来，保加利亚已向乌克兰提供了13批武器援助。但今年拉德夫政府上台后，对乌政策发生了转变。（央视新闻）

The AI IPO parade keeps growing. Perplexity is locked in for 2028, but the market is holding its breath for SpaceX's debut on Friday.

恐慌指数VIX达到自4月7日以来的最高点；最新上涨2.72点，报21.64。

Key PointsPaul Sarvadi purchased 233,000 shares at a weighted average price of $34.05 per share on June 3, 2026, for a total outlay of ~$7.93 million.

Over the past decade, passive investing has reshaped much of the investment landscape, but fixed income presents a different set of challenges and opportunities. In this episode of Inside Active, host David Cohne, mutual fund and active-management analyst at Bloomberg Intelligence, spoke with Noah Wise, senior portfolio manager and head of global macro strategy for the Plus Fixed Income team at Allspring Global Investments about why active management may have a stronger case in bonds than in equ

Key PointsMission Produce saw sales decline 24% as avocado pricing declined while volume rose as the market "normalized."

Meta Platforms计划利用其从商家处收集的数据，来进一步个性化用户在其社交媒体平台上看到的内容。 Meta周二表示，将利用商家已发送给它的数据，例如用户玩的游戏或在其他网站上进行的购买，来个性化用户在社交媒体信息流中看到的内容以及由人工智能生成的回应。例如，一位最近在网上购买了帐篷的用户，可能会看到更多关于露营的短视频。 这家长期以来一直利用其他商家数据投放定向广告的公司表示，此次更新不会收集任何新的数据。 该公司在一篇博客文章中表示：“此举旨在利用商家已发送给我们的信息，进一步改善您的体验。” 作为此次更新的一部分，Meta表示还将精简其设置选项，以便用户控制该公司如何获取和使用其他商家分享的数据。 Meta表示将停止提供“Meta平台外动态”设置，该设置允许用户将商家与公司分享的动态与自己的账户解除关联。该公司表示，将转而扩展“来自其他商家的动态”设置，允许用户选择是否允许Meta使用这些数据来展示更个性化的内容和广告。 Facebook和Instagram的母公司Meta表示，这些控制和数据使用方面的调整将于下月在美国和其他一些国家生效，之后会推广到更多国家。 责任编辑：李桐

【有線新聞】美國太空總署公布明年底執行阿提密斯三號探月任務的太空人名單。 四名太空人名單包括三個美國人道格拉斯、魯維奧和布雷斯尼克，以及歐洲太空總署的意大利太空人帕爾米塔諾。美國太空總署指這次是激動人心、複雜且高度協調的多火箭發射計劃，短時間內發射3枚火箭對接。 當局預計明年底會先發射藍色起源的「藍月」著陸器，之後到搭載太空人的獵戶座太空船升空，對接兩天進行測試和技術展示後，獵戶座會分離等待SpaceX的星艦飛船升空，完成對接後返回地球。

TOULON, France, June 09, 2026--Kontron, a leading global provider of IoT/Embedded Computer Technology (ECT), today announces the VX33211, a high-performance 3U VPX GPU board designed to deliver advanced graphics, AI inference, sensor processing, and GPGPU acceleration in rugged embedded environments.

Just months after temporarily shuttering all its retail stores in the United Arab Emirates amid escalating geopolitical tensions, Apple is making another significant adjustment to its retail footprint, this time in the U.S. The technology giant has confirmed plans to permanently close three Apple ...

布伦特原油价格跌破每桶90美元，触及4月以来的最低水平。越来越多迹象显示全球需求正在急剧萎缩，抵消伊朗战争导致的供应损失影响。 周二交易时段，油价跌幅超过4%。投资者在市场需求减弱以及全球库存急剧下降之间进行权衡。这也是布伦特原油自4月17日以来首次跌破90美元关口。 责任编辑：李桐

Revlon Group Holdings LLC didn’t properly test products for cancer-causing chemicals or mold, US regulators warned the beauty giant in a letter posted Tuesday. The Food and Drug Administration called one Revlon product higher risk because of its potential to be contaminated with a known human carcinogen in the letter dated June 2. The details of the product and the potential contaminant were redacted from the public version of the letter. Revlon didn’t immediately respond to requests for comment. Revlon told the FDA that its supplier analyzed product components, though the agency said Revlon had not verified the suppliers’ test methods were reliable, according to the letter. In recent years, personal-care products such as spray-on sunscreens and antiperspirants, hand sanitizers and acne treatments have been recalled. The recalls were triggered by contamination with a carcinogen called benzene , which is linked to leukemia. The redacted FDA letter doesn’t indicate whether benzene was the carcinogen the agency was concerned about. Revlon’s quality unit also failed to test for multiple impurities and permitted more yeast and mold than standard tests allow, the letter states. The agency asked for “a comprehensive assessment and remediation plan” to ensure Revlon’s quality unit can effectively function. “As a manufacturer, you have a responsibility to sample, test, and examine, as appropriate, drug components before use in production,” the FDA wrote. It’s the latest setback for closely held Revlon. The company was taken over by creditors three years ago as part of a bankruptcy process that capped years of creditor infighting. An earlier debt deal didn’t solve its struggles . Revlon and several other beauty product makers faced allegations from consumers in recent years linking hair relaxers to some types of cancer. An attorney representing Revlon when many claims were made said in 2023 the company disputed any link between its hair relaxers and cancer. The litigation is ...

特斯拉 已获准在丹麦推出其一套先进的驾驶辅助功能。 对于正寻求将该技术推向更多市场的特斯拉而言，这是一大利好。 丹麦道路交通管理局周二表示，将允许特斯拉车主使用该公司的全自动驾驶（受驾驶员监督）系统。该系统可帮助车辆变换车道、绕开其他车辆和物体。该机构称，此举是因为该系统有助于提升道路安全。 特斯拉在社交平台上发文称，将很快开始在丹麦推广该技术。根据特斯拉网站上的信息，全自动驾驶（FSD）系统并不能使车辆完全自动驾驶，只能由注意力完全集中的驾驶员来使用。 丹麦由此成为欧盟第四个批准FSD的国家，此前已有爱沙尼亚、立陶宛和荷兰三国批准。荷兰车辆管理局（RDW）今年4月表示，该系统经过了一年半多的测试，正确使用对道路安全有积极作用。 该机构已提交申请，希望这项技术能在整个欧盟获批。不过，在欧盟有关部门审议该申请期间，各个国家可以先行认可荷兰的批准，允许特斯拉推广FSD。 丹麦道路交通管理局表示，在欧盟全境批准该系统之前，该局已选择暂时认可荷兰的批准。但如果该系统被欧盟驳回，荷兰的批准将在六个月后失效，丹麦的批准也将随之失效。 责任编辑：李桐

Treasuries rose as benchmark oil prices declined to the lowest levels in more than a month, alleviating concern about elevated inflation ahead of Wednesday’s release of the May consumer price index. The advance on Tuesday pushed yields across maturities lower by three to five basis points at around 12:20 p.m. New York time, near session lows. US benchmark West Texas Intermediate crude oil futures fell more than 5%, global benchmark Brent crude more than 4%, both to the lowest level in more than a month. Oil’s retreat from multiyear highs reached in April has eased concern that US inflation gauges will remain elevated. A key gauge of price pressures scheduled to be released Wednesday is expected to show further acceleration from the highest levels since 2023. The consumer price index in April rose 3.8% from a year earlier, 2.8% excluding food and energy. Rates of 4.2% and 2.9% are seen for May, the median estimates in a Bloomberg survey of economists. While oil prices since late February have mainly been guided by developments in the US war on Iran, which has curtailed Middle East supply, Tuesday’s drop was sparked by data showing that the surge in prices eroded Chinese demand in May. The Treasury market rally trimmed the expected yield for the first of this week’s three longer-term debt auctions at 1 p.m. New York time, a $58 billion three-year new issue. The indicated yield declined to about 4.17%. In trading since the auction was announced on June 4, the yield has been as high as 4.25%.

One day after WIRED revealed that Meta had quietly embedded an unreleased face-recognition system into an app installed on more than 50 million phones, the company removed it, according to a WIRED analysis of the latest version’s code. The most recent version of Meta AI, a companion app for its line of smart glasses , strips out the unactivated software components that powered the system Meta internally called NameTag. The version published the day of WIRED’s report included several code libraries explicitly named for face recognition. Friday’s release includes none of them. Andy Stone, Meta's vice president of communications, told WIRED on Monday that the feature is purely exploratory, adding: “No final decision has been made on what to do here, if anything.” Read full article Comments

SpaceX and Tesla Inc. CEO Elon Musk hailed investor Ron Baron after the latter predicted that SpaceX could go on to become the most profitable and valuable company of all time ahead of its anticipated IPO. SpaceX To $30 Trillion?...

Michael Gonzalez/Getty Images News A group of current and former SpaceX ( SPCX ) employees is banding together to negotiate lower-cost wealth management services as the company's highly anticipated IPO creates a new class of multimillionaires. The group, which includes more than 100 members, has partnered with registered investment advisor Choreo to offer an investment-management program with fees below typical industry levels, CNBC reported, citing people familiar with the arrangement. The employees collectively represent between $1 billion and $5 billion in potential wealth tied to SpaceX ( SPCX ) shares. The initiative grew out of an informal network where employees discussed philanthropy and financial planning ahead of the company's stock market debut. Representatives from the group evaluated several advisory firms before reaching an agreement with Chicago-based Choreo, which oversees more than $28 billion in client assets and advisement. While financial terms were not disclosed, participants said the arrangement includes annual management fees below 0.5% of assets, lower than the roughly 0.5% to 1% commonly charged by wealth management firms. The agreement is designed as a long-term offering rather than a temporary promotional discount. The effort reflects a broader shift in how newly wealthy investors may approach financial services. By pooling their assets, the SpaceX employees were able to negotiate pricing typically unavailable to individuals acting alone. At a targeted valuation of roughly $1.8 trillion in the IPO, SpaceX’s ( SPCX ) would immediately rank among the world’s most valuable public companies. Many SpaceX ( SPCX ) workers accumulated significant equity stakes after accepting stock compensation in lieu of higher salaries during the company's years as a private enterprise. With the company scheduled to begin trading publicly this week, employees are preparing to manage substantial newfound wealth. Some members of the group have discussed directing...

Micron is scheduled to report earnings on June 24.

Viewership for previous World Cup finals was only a little higher than for a strong Monday Night Football game, but with matches on U.S. soil, media executives are hopeful this will be the year soccer breaks through.

Key PointsShares of Micron Technology have soared nearly 50% over the last month.

Prediction: This Artificial Intelligence (AI) Semiconductor Stock Will Go Parabolic in June (Hint: It's Not Nvidia) Yahoo Finance

fadfebrian Parabilis Medicines ( PBLS ) has filed for an upsized initial public offering in the U.S., seeking to raise more than $600M as the cancer drug developer backed by Regeneron ( REGN ) targets a valuation of up to $2.3B. In an amended S-1 filing submitted to the SEC on Tuesday, the Cambridge, Massachusetts-based firm disclosed plans to offer more than 33.3M shares of its common stock at a range of $17-$19 each. At the midpoint of the range, the company expects to raise $636.8M in net proceeds, assuming underwriters fully exercise their overallotment option. Parabilis ( PBLS ) could command a valuation of more than $2.3B at the top of the range, based on the total number of shares expected to remain outstanding immediately after the offering. Last week, the peptide-based treatment developer set its IPO terms, indicating plans to offer 25M shares to generate $476.4M in net proceeds at a valuation of up to $2.2B. Parabilis' ( PBLS ) IPO comes close on the heels of its recent research agreement worth up to $2.3B with Regeneron ( REGN ), which has agreed to buy nearly $75M of company shares under a concurrent private placement linked to the deal. More on Parabilis Medicines, Inc. Parabilis Medicines Starts IPO On Promising Cancer Therapy Trials Regeneron backed Parabilis seeks up to $476M in U.S. IPO Regeneron backed Parabilis Medicines seeks U.S. IPO Financial information for Parabilis Medicines, Inc.